February 26/Kawasaki, Japan/Healthcare Finance, Tax & Law Weekly -- Investigators have published new data in the report "Effects of safflower seed extract supplementation on oxidation and cardiovascular risk markers in healthy human volunteers."
According to recent research from Kawasaki, Japan, "We previously demonstrated that safflower seed extract (SSE) and its major antioxidant constituents, serotonin hydroxycinnamic acid amides, suppressed LDL oxidation in vitro, decreased plasma autoantibody titres to oxidized LDL and attenuated atherosclerotic lesion formation in apoE-deficient mice. In this report, we examined whether SSE, rich in serotonin derivatives, could affect markers of oxidative stress, inflammation and aortic stiffness in healthy human subjects."